Document is current
Any future updates will be listed below
-
Authors
Shou, Liumei
Chen, Jialu
Shao, Tianyu
Zhang, Yao
Zhao, Shuya
Chen, Shuyi
Shu, Qijin
-
Funding
Funding for this research was provided by:
the Project of science and technology of Traditional Chinese Medicine of Zhejiang Province (NO. 2020ZB076, 2022ZB113)
"the Postgraduate Scientific Research Fund" of Zhejiang Chinese Medical University (2021YKJ03)
the Scientific Research Fund of Zhejiang Provincial Education Department (Y202145970)
the Key Pilot Program of Integrative Chinese and Western Medicine for Refractoriness Disease
- License Information
-
More Information
Article History
Received: 22 December 2022
Accepted: 22 May 2023
First Online: 5 June 2023
Declarations
:
: This study was approved by the ethics committee of the First Affiliated Hospital of Zhejiang Chinese Medical University (2021–10-11 / 2021-KL-169–01). And the study of patient serum samples was approved by the Ethics Committee of the First Affiliated Hospital of Zhejiang Chinese Medical University (2017–06-19 / 2017-X-046). This study was performed in accordance with the Ethical Standards of the World Medical Association Declaration of Helsinki.
: This is a retrospective study. The ethics committee of the First Affiliated Hospital of Zhejiang Chinese Medical University has confirmed that it is not necessary to obtain consent. And for 19 patients of blood donors, signed informed consent was obtained.
: The authors affirm that human research participant provided informed consent for publication of the images in Fig. InternalRef removed.
: The authors have no relevant financial or non-financial interests to disclose.
